Amaia Lujambio

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 24

Top Venues

Hepatology (Baltimore, Md.)

Gut

Nature medicine

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Sandra Santasusagna, Shijia Zhu, Vijayakumar Jawalagatti, Marc Carceles-Cordon, Adam Ertel, Saioa Garcia-Longarte, Won-Min Song, Naoto Fujiwara, Peiyao Li, Isabel Mendizabal, Daniel P Petrylak, William Kevin Kelly, E Premkumar Reddy, Liguo Wang, Matthew J Schiewer, Amaia Lujambio, Robert Jeffrey Karnes, Beatrice Knudsen, Carlos Cordon-Cardo, Haidong Dong, Zhenlin Huang, Arkaitz Carracedo, Yujin Hoshida, Veronica Rodriguez-Bravo, Josep Domingo-Domenech
Master transcription factor reprograming unleashes selective translation promoting castration resistance and immune evasion in lethal prostate cancer. Cancer discovery (2023)
Alex Rialdi, Mary Duffy, Alex P Scopton, Frank Fonseca, Julia Nanyi Zhao, Megan Schwarz, Pedro Molina-Sanchez, Slim Mzoughi, Elisa Arceci, Jordi Abril-Fornaguera, Austin Meadows, Marina Ruiz de Galarreta, Denis Torre, Kyna Reyes, Yan Ting Lim, Felix Rosemann, Zaigham M Khan, Kevin Mohammed, Xuedi Wang, Xufen Yu, Manikandan Lakshmanan, Ravisankar Rajarethinam, Soo Yong Tan, Jian Jin, Augusto Villanueva, Eleftherios Michailidis, Ype P De Jong, Charles M Rice, Ivan Marazzi, Dan Hasson, Josep M Llovet, Radoslaw Mikolaj Sobota, Amaia Lujambio, Ernesto Guccione, Arvin C Dar
WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinoma. Nature cancer (2023)
Zhihong Chen, Nishant Soni, Gonzalo Pinero, Bruno Giotti, Devon J Eddins, Katherine E Lindblad, James L Ross, Montserrat Puigdelloses Vallcorba, Tanvi Joshi, Angelo Angione, Wes Thomason, Aislinn Keane, Nadejda M Tsankova, David H Gutmann, Sergio A Lira, Amaia Lujambio, Eliver Eid Bou Ghosn, Alexander M Tsankov, Dolores Hambardzumyan
Monocyte depletion enhances neutrophil influx and proneural to mesenchymal transition in glioblastoma. Nature communications 14 (1) (2023)
Romain Donne, Amaia Lujambio
The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma. Hepatology (Baltimore, Md.) (2022)
Miguel A Martin-Serrano, Benjamin Kepecs, Miguel Torres-Martin, Emily R Bramel, Philipp K Haber, Elliot Merritt, Alexander Rialdi, Nesteene Joy Param, Miho Maeda, Katherine E Lindblad, James K Carter, Marina Barcena-Varela, Vincenzo Mazzaferro, Myron Schwartz, Silvia Affo, Robert F Schwabe, Augusto Villanueva, Ernesto Guccione, Scott L Friedman, Amaia Lujambio, Anna Tocheva, Josep M Llovet, Swan N Thung, Alexander M Tsankov, Daniela Sia
Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications. Gut (2022)
Katherine E Lindblad, Amaia Lujambio
Imaging for better responses to immunotherapy in hepatocellular carcinoma. Hepatology (Baltimore, Md.) (2022)
Andrew X Zhu, Alexander R Abbas, Marina Ruiz de Galarreta, Yinghui Guan, Shan Lu, Hartmut Koeppen, Wenjun Zhang, Chih-Hung Hsu, Aiwu Ruth He, Baek-Yeol Ryoo, Thomas Yau, Ahmed O Kaseb, Adam M Burgoyne, Farshid Dayyani, Jessica Spahn, Wendy Verret, Richard S Finn, Han Chong Toh, Amaia Lujambio, Yulei Wang
Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma. Nature medicine 28 (8) (2022)
Amanda J Craig, Teresa Garcia-Lezana, Marina Ruiz de Galarreta, Carlos Villacorta-Martin, Edgar G Kozlova, Sebastiao N Martins-Filho, Johann von Felden, Mehmet Eren Ahsen, Erin Bresnahan, Gabriela Hernandez-Meza, Ismail Labgaa, Delia D'Avola, Myron E Schwartz, Josep M Llovet, Daniela Sia, Swan Thung, Bojan Losic, Amaia Lujambio, Augusto Villanueva
Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma. PLoS genetics 17 (6) (2021)
Polona Safaric Tepes, Debjani Pal, Trine Lindsted, Ingrid Ibarra, Amaia Lujambio, Vilma Jimenez Sabinina, Serif Senturk, Madison Miller, Navya Korimerla, Jiahao Huang, Lawrence Glassman, Paul Lee, David Zeltsman, Kevin Hyman, Michael Esposito, Gregory J Hannon, Raffaella Sordella
An epigenetic switch regulates the ontogeny of AXL-positive/EGFR-TKi-resistant cells by modulating miR-335 expression. eLife 10 (2021)
Chaobo Chen, Hanghang Wu, Hui Ye, Agustín Tortajada, Sandra Rodríguez-Perales, Raúl Torres-Ruiz, August Vidal Bel, Maria Isabel Peligros, Johanna Reissing, Karen Schmidt, Mohamed Ramadan Mohamed, Kang Zheng, Amaia Lujambio, Maria J Iraburu, Leticia Colyn, Maria Ujue Latasa, María Arechederra, Maite G Férnandez-Barrena, Carmen Berasain, Javier Vaquero, Rafael Bañares, Leonard J Nelson, Christian Trautwein, Roger J Davis, Eduardo Martinez-Naves, Yulia A Nevzorova, Alberto Villanueva, Matias A Avila, Francisco Javier Cubero
Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver Disease. Cancers 14 (1) (2021)
Junyan Tao, Yekaterina Krutsenko, Akshata Moghe, Sucha Singh, Minakshi Poddar, Aaron Bell, Michael Oertel, Aatur D Singhi, David Geller, Xin Chen, Amaia Lujambio, Silvia Liu, Satdarshan Paul Monga
Nuclear factor erythroid 2-related factor 2 and β-Catenin Coactivation in Hepatocellular Cancer: Biological and Therapeutic Implications. Hepatology (Baltimore, Md.) 74 (2) (2021)
Katherine E Lindblad, Amaia Lujambio
Liver metastases inhibit immunotherapy efficacy. Nature medicine 27 (1) (2021)
Marina Bárcena-Varela, Amaia Lujambio
Dissecting Early Relapse in Liver Cancer, One Cell at a Time. Hepatology (Baltimore, Md.) 74 (5) (2021)
Dominik Pfister, Nicolás Gonzalo Nuñez, Roser Pinyol, Olivier Govaere, Matthias Pinter, Marta Szydlowska, Revant Gupta, Mengjie Qiu, Aleksandra Deczkowska, Assaf Weiner, Florian Müller, Ankit Sinha, Ekaterina Friebel, Thomas Engleitner, Daniela Lenggenhager, Anja Moncsek, Danijela Heide, Kristin Stirm, Jan Kosla, Eleni Kotsiliti, Valentina Leone, Michael Dudek, Suhail Yousuf, Donato Inverso, Indrabahadur Singh, Ana Teijeiro, Florian Castet, Carla Montironi, Philipp K Haber, Dina Tiniakos, Pierre Bedossa, Simon Cockell, Ramy Younes, Michele Vacca, Fabio Marra, Jörn M Schattenberg, Michael E D Allison, Elisabetta Bugianesi, Vlad Ratziu, Tiziana Pressiani, Antonio D'Alessio, Nicola Personeni, Lorenza Rimassa, Ann K Daly, Bernhard Scheiner, Katharina Pomej, Martha M Kirstein, Arndt Vogel, Markus Peck-Radosavljevic, Florian Hucke, Fabian Finkelmeier, Oliver Waidmann, Jörg Trojan, Kornelius Schulze, Henning Wege, Sandra Koch, Arndt Weinmann, Marco Bueter, Fabian Rössler, Alexander Siebenhüner, Sara De Dosso, Jan Philipp Mallm, Viktor Umansky, Manfred Jugold, Tom Luedde, Andrea Schietinger, Peter Schirmacher, Brinda Emu, Hellmut G Augustin, Adrian Billeter, Beat Müller-Stich, Hiroto Kikuchi, Dan G Duda, Fabian Kütting, Dirk-Thomas Waldschmidt, Matthias Philip Ebert, Nuh Rahbari, Henrik E Mei, Axel Ronald Schulz, Jane A McKeating, Nisar Malek, Stephan Spahn, Michael Bitzer, Marina Ruiz de Galarreta, Amaia Lujambio, Jean-François Dufour, Thomas U Marron, Ahmed Kaseb, Masatoshi Kudo, Yi-Hsiang Huang, Nabil Djouder, Katharina Wolter, Lars Zender, Parice N Marche, Thomas Decaens, David James Pinato, Roland Rad, Joachim C Mertens, Achim Weber, Kristian Unger, Rüdiger Klein, Susanne Roth, Zuzana Macek Jilkova, Manfred Claassen, Quentin M Anstee, Bjørt K Kragesteen, Percy A Knolle, Burkhard Becher, Josep M Llovet, Mathias F Heikenwälder
NASH limits anti-tumour surveillance in immunotherapy-treated HCC. Nature 592 (7854) (2021)
Marina Barcena-Varela, Amaia Lujambio
A Novel Long Noncoding RNA Finetunes the DNA Damage Response in Hepatocellular Carcinoma. Cancer research 81 (19) (2021)
Camille Bigenwald, Jessica Le Berichel, C Matthias Wilk, Rikhia Chakraborty, Steven T Chen, Alexandra Tabachnikova, Rebecca Mancusi, Harshal Abhyankar, Maria Casanova-Acebes, Ilaria Laface, Guray Akturk, Jenielle Jobson, Zoi Karoulia, Jerome Christophe Martin, John Grout, Anahita Rafiei, Howard Lin, Markus Gabriel Manz, Alessia Baccarini, Poulikos I Poulikakos, Brian D Brown, Sacha Gnjatic, Amaia Lujambio, Kenneth L McClain, Jennifer Picarsic, Carl E Allen, Miriam Merad
BRAFV600E-induced senescence drives Langerhans cell histiocytosis pathophysiology. Nature medicine 27 (5) (2021)
Chantal Desdouets, Amaia Lujambio
Decoding therapy resistance in liver tumours: a giant leap. Nature reviews. Gastroenterology & hepatology (2021)
Erin Bresnahan, Katherine E Lindblad, Marina Ruiz de Galarreta, Amaia Lujambio
Mouse Models of Oncoimmunology in Hepatocellular Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (20) (2020)
Pedro Molina-Sánchez, Amaia Lujambio
Iron overload and liver cancer. The Journal of experimental medicine 216 (4) (2019)
Marina Ruiz de Galarreta, Amaia Lujambio
Hepatocellular carcinoma: killing one bird with two stones. Gut 68 (9) (2019)
Jia Xin Yu, Amanda J Craig, Mary E Duffy, Carlos Villacorta-Martin, Verónica Miguela, Marina Ruiz de Galarreta, Alexander P Scopton, Lisa Silber, Andres Y Maldonado, Alexander Rialdi, Ernesto Guccione, Amaia Lujambio, Augusto Villanueva, Arvin C Dar
Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC Polypharmacology. Molecular cancer therapeutics 18 (9) (2019)
Marina Ruiz de Galarreta, Erin Bresnahan, Pedro Molina-Sánchez, Katherine E Lindblad, Barbara Maier, Daniela Sia, Marc Puigvehí, Verónica Miguela, María Casanova-Acebes, Maxime Dhainaut, Carlos Villacorta-Martin, Aatur D Singhi, Akshata Moghe, Johann von Felden, Lauren Tal Grinspan, Shuang Wang, Alice Oliffson Kamphorst, Satdarshan P Monga, Brian D Brown, Augusto Villanueva, Josep M Llovet, Miriam Merad, Amaia Lujambio
β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma. Cancer discovery 9 (8) (2019)
Amaia Lujambio
To clear, or not to clear (senescent cells)? That is the question. BioEssays : news and reviews in molecular, cellular and developmental biology (2017)
Julien Bollard, Verónica Miguela, Marina Ruiz de Galarreta, Anu Venkatesh, C Billie Bian, Mark P Roberto, Victoria Tovar, Daniela Sia, Pedro Molina-Sánchez, Christie B Nguyen, Shigeki Nakagawa, Josep M Llovet, Yujin Hoshida, Amaia Lujambio
Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma. Gut 66 (7) (2016)

Amaia Lujambio.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Amaia Lujambio